The Current Ratio as of December 2025 (TTM) for Abnova (Taiwan) Corporation (4133.TW) is 7.83

According to Abnova (Taiwan) Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 7.83. This represents a change of -29.88% compared to the average of 11.17 of the last 4 quarters.

Abnova (Taiwan) Corporation (4133.TW) Historical Current Ratio (quarterly & annually)

How has 4133.TW Current Ratio performed in the past?

The mean historical Current Ratio of Abnova (Taiwan) Corporation over the last ten years is 12.26. The current 7.83 Current Ratio has changed 6.29% with respect to the historical average. Over the past ten years (40 quarters), 4133.TW's Current Ratio was at its highest in in the December 2024 quarter at 14.95. The Current Ratio was at its lowest in in the June 2021 quarter at 6.95.

Abnova (Taiwan) Corporation (4133.TW) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Abnova (Taiwan) Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Abnova (Taiwan) Corporation (4133.TW) Average Current Ratio

How has 4133.TW Current Ratio performed in the past?

The current Current Ratio of Abnova (Taiwan) Corporation (4133.TW) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Abnova (Taiwan) Corporation (4133.TW) Current Ratio vs. Peers

How is 4133.TW’s Current Ratio compared to its peers?

Abnova (Taiwan) Corporation’s Current Ratio is less than NaviFUS Corp. (15.39), greater than Enimmune corporation (1.41), greater than BiOptic Inc. (6.27), greater than GenMont Biotech Incorporation (4.38), greater than GeneReach Biotechnology Corp. (2.23), less than Great Novel Therapeutics Biotech & Medicals (30.32), greater than Meribank Biotech Co., Ltd (1.58), greater than NeoCore Technology Co., Ltd. (1.59), greater than MegaPro Biomedical Co., Ltd (4.34), greater than Taiwan Advance Bio-Pharmaceutical Inc. (0.90),

Build a custom stock screener for Abnova (Taiwan) Corporation (4133.TW) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Abnova (Taiwan) Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Abnova (Taiwan) Corporation (4133.TW) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Abnova (Taiwan) Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.